‌

‌

‌
‌
‌‌

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications

Real-world outcomes of datopotamab deruxtecan after trastuzumab deruxtecan in hormone receptor-positive, HER2-negative metastatic breast cancer.

Real-world outcomes of datopotamab deruxtecan after trastuzumab deruxtecan in hormone receptor-positive, HER2-negative metastatic breast cancer.

Journal: Breast cancer (Tokyo, Japan)
Published: July 02, 2026

Molecular pathology quality control in Southeast Asia: Results of a multiregional quality assurance study from MASTER KEY Asia.

Molecular pathology quality control in Southeast Asia: Results of a multiregional quality assurance study from MASTER KEY Asia.

Journal: Cancer science
Published: December 24, 2022

Serial circulating tumor DNA monitoring of CDK4/6 inhibitors response in metastatic breast cancer.

Serial circulating tumor DNA monitoring of CDK4/6 inhibitors response in metastatic breast cancer.

Journal: Cancer science
Published: December 01, 2021

Assessment of a cancer genomic profile test for patients with metastatic breast cancer.

Assessment of a cancer genomic profile test for patients with metastatic breast cancer.

Journal: Scientific reports
Published: September 25, 2021

The impact of obesity and endocrine therapy on the prognosis of premenopausal women with hormone receptor-positive breast cancer: A single-institute retrospective study.

The impact of obesity and endocrine therapy on the prognosis of premenopausal women with hormone receptor-positive breast cancer: A single-institute retrospective study.

Journal: Cancer reports (Hoboken, N.J.)
Published: September 07, 2021

Myocardial dysfunction caused by abemaciclib: a case report.

Myocardial dysfunction caused by abemaciclib: a case report.

Journal: International cancer conference journal
Published: June 18, 2021

Trastuzumab and fulvestrant combination therapy for women with advanced breast cancer positive for hormone receptor and human epidermal growth factor receptor 2: a retrospective single-center study.

Trastuzumab and fulvestrant combination therapy for women with advanced breast cancer positive for hormone receptor and human epidermal growth factor receptor 2: a retrospective single-center study.

Journal: BMC cancer
Published: February 15, 2021

Utility of Preoperative Computed Tomography Scans for Coronavirus Disease in a Cancer Treatment Center.

Utility of Preoperative Computed Tomography Scans for Coronavirus Disease in a Cancer Treatment Center.

Journal: Cancer cell
Published: December 19, 2020

A Phase II study of the safety and efficacy of lenvatinib in patients with advanced thyroid cancer.

A Phase II study of the safety and efficacy of lenvatinib in patients with advanced thyroid cancer.

Journal: Future oncology (London, England)
Published: January 15, 2019

Lenvatinib for Anaplastic Thyroid Cancer.

Lenvatinib for Anaplastic Thyroid Cancer.

Journal: Frontiers in oncology
Published: December 05, 2016

Predictive factors of head and neck squamous cell carcinoma patient tolerance to high-dose cisplatin in concurrent chemoradiotherapy.

Predictive factors of head and neck squamous cell carcinoma patient tolerance to high-dose cisplatin in concurrent chemoradiotherapy.

Journal: Molecular and clinical oncology
Published: June 02, 2015

Differences in the responses to pazopanib and the prognoses of soft tissue sarcomas by their histological eligibility for the PALETTE study.

Differences in the responses to pazopanib and the prognoses of soft tissue sarcomas by their histological eligibility for the PALETTE study.

Journal: Japanese journal of clinical oncology
Published: December 16, 2014
Showing 1-12 of 13

Last Updated: 09/26/2026